Crystallization Process Development​

Crystallization plays a pivotal role in shaping the quality, performance, and scalability of Active Pharmaceutical Ingredients (APIs). From achieving high purity and yield to ensuring reproducible manufacturing, crystallization optimization is essential to pharmaceutical development. 

Optimizing crystallization for better drug development outcomes

At Solitek, we combine cutting-edge technologies, predictive modeling, and tailored strategies to refine crystallization processes. Our expertise helps pharmaceutical companies overcome complex challenges, ensuring the crystalline form and particle properties meet stringent regulatory and therapeutic requirements. 

Our approach combines advanced analytical techniques, predictive modeling, and a client-focused mindset. From controlling crystalline form and particle size distribution to mitigating risks like wrong crystalline form or morphology or the presence of excessive residual solvent, we guide your project to success by ensuring robust crystallization processes that align with your drug development goals.

Key concepts

Developing a robust crystallization process offers multiple benefits for pharmaceutical development: 

  • Enhanced drug performance: Consistent particle size and crystal habit improve drug dissolution and bioavailability. 
  • Improved manufacturability: Scalable processes ensure reproducibility and streamline production. 
  • Greater purity and yield: Achieving high-quality crystalline forms reduces impurities and maximizes API production. 
  • Reduced drug formulation challenges: Controlling particle attributes to facilitate the development and manufacturing of optimal drug formulations to improve therapeutic outcomes. 
  • Risk mitigation: Identifies and addresses potential challenges during scale-up and manufacturing. 

At Solitek, we leverage state-of-the-art tools to optimize every stage of the crystallization process: 

  • Particle Size Distribution Control: Precise tuning of nucleation and growth parameters to ensure uniform particle attributes. 
  • Polymorphic Stability Assessment: Identifying stable crystalline forms, including monotropic and enantiotropic polymorphs. 
  • Seeding Optimization: Adjusting seeding temperatures and conditions, sometimes by just a few degrees, to improve reproducibility and achieve desired crystal morphology. 
  • Process Analytical Technology (PAT): Real-time monitoring for in-process control and reduced variability. 
  • Solvent System Selection: Optimizing the solubility curve and metastable zone width for efficient crystallization. 
  • Anti-solvent Addition: Controlled rates to achieve desired supersaturation levels without unwanted agglomerates. 

Our Crystallization process development services are critical at various stages of drug development: 

  • API Development: Optimizing the purity and scalability of active pharmaceutical ingredients. 
  • Formulation Design: Controlling particle attributes to facilitate the development and manufacturing of optimal drug formulations for improved therapeutic outcomes.  
  • Manufacturing Scalability: Ensuring consistent performance during production scale-up. 
  • Regulatory Compliance: Producing data-driven processes that meet stringent pharmaceutical standards. 

At Solitek, we pride ourselves on our ability to adapt to the unique needs of each client. Our client-focused approach ensures that every project benefits from tailored solutions and expert insights: 

  • Customized strategies: Designed to meet specific development and manufacturing goals. 
  • Innovative techniques: Incorporating predictive models and real-time analytics for superior outcomes. 
  • Comprehensive support: From early-stage development to full-scale manufacturing. 

Partnering with Solitek means access to: 

  • Expertise in Crystallization Science: Decades of experience in delivering successful outcomes for challenging projects. 
  • State-of-the-Art Technology: Advanced tools to monitor and optimize every stage of crystallization. 
  • Commitment to Quality: Ensuring consistent and reliable processes that meet regulatory standards. 
  • Formulation Optimization: Supporting the development of optimal drug delivery systems by ensuring consistency of crystalline form and particle attributes. 

Case Studies and Success Stories

Our track record highlights our ability to tackle difficult crystallization challenges with innovative solutions: 

Enhanced API purity and yield: Developed scalable processes that significantly improved the quality of APIs, ensuring compliance with regulatory standards. 

Consistent particle size and crystal habit: Achieved through precise control of crystallization parameters, streamlining manufacturability. 

Discovery of pure phases: Isolated novel crystalline forms, previously unavailable, improving drug performance and IP potential. 

Seeding temperature optimization: Adjusted temperatures to achieve consistent crystalline forms, improving batch reproducibility. 

Risk assessment and mitigation: Helped clients anticipate and address potential scale-up issues, avoiding costly delays in production. 

Contact us

Looking to optimize your crystallization processes for pharmaceutical development? Partner with Solitek for tailored solutions that deliver consistency, scalability, and superior results. Contact us today to learn how we can transform your drug development pipeline.